InvestorsHub Logo
icon url

Steve43

04/10/20 11:13 AM

#222481 RE: art2426 #222479

First things first, clear up this, we have deals situation, cause if they ain't there, it brings everything down. We pushed everything into the OEM design plan of business making future sales dependent on the OEM and it's marketing. Were the two big orders to Mundi, the cause in the rise of sales, cause we hear nothing about pushing sales or the CE Mark. The CEO's message was all about OEM and how they were going to take care of all sales and marketing along with I believe manufacturing. So we wait for these deals to be finalized. We still don't know how this OEM plan effects normal sales of product, will we be out of retail all together? We know nothing other than the CEO likes bike riding and posting HealFast animal pictures. Give her 3 more quarters? Good luck with that as she is already building an image and perception.. We need to clear up this immediate situation or IMO there'll be no future. JMHO GLTY
icon url

4toSchool

04/10/20 12:12 PM

#222493 RE: art2426 #222479

I hope that I am wrong, but IMO, we are going to see 1st Quarter sales drop like a rock from the 4th quarter 2019. Why, because KN hasn't tweeted about any new purchase orders from Pharmalink and Mundipharma, the two customers that collectively placed purchase orders 29,000 back in the 4th quarter.

$583,963 Sales through 9-30-2019
941,761 Sales through 12-31-2019
$357,798 Therefore 4th Quarter sales totaled
29,000 units ordered by PharmaLink and MundiPharma
$12.34 average revenue per unit if 100% of sales were resulting from PharmaLink and MundiPharma's orders totaling 29,000 units.

$10.00 Hypothetical price per unit sold
35,780 Hypothetical # units sold in the 4th Qtr.

$8.00 Hypothetical price per unit sold
44,725 Hypothetical # units sold in the 4th Qtr.

Any way you slice it, PharmaLink and Mudipharma were the revenue generating 4th Qtr. customers.

"I will give this CEO a couple quarters to see if we get that PROGRESS and IMPROVEMENT. Give us consecutive quarters of increased sales to show us stockholders that we might be headed in the right direction"